Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Walgreens Boots Alliance (WBA) has sold approximately 15.5 million shares of Option Care Health (OPCH), raising funds at $30.75 per share. This includes 13.0 million shares in an underwritten secondary offering and a concurrent repurchase of 2.5 million shares by OPCH. Following the sale, WBA's ownership in OPCH decreased from 14% to 6%. The proceeds will primarily be allocated for debt paydown and to support WBA's strategic initiatives.
Option Care Health (NASDAQ: OPCH) announced a secondary offering of 13 million shares by an affiliate of Walgreens Boots Alliance, with no proceeds going to the company. Concurrently, Option Care plans to repurchase shares worth approximately $75 million from the selling stockholder, funded by cash on hand. The repurchase is contingent on the closing of the offering, which is underwritten by Goldman Sachs. The company emphasizes its role as the largest independent provider of home infusion services, catering to patients across 50 states.
Option Care Health (Nasdaq: OPCH) reported its financial results for Q4 and the full year 2022, showcasing a 10.8% increase in net revenue to $1,027.2 million compared to Q4 2021. Gross profit rose 8.9% to $231.1 million, representing 22.5% of revenue. However, net income fell to $47.5 million or $0.26 EPS, down from $75.5 million or $0.42 EPS a year prior. For the full year, net revenue grew 14.7% to $3,944.7 million, with net income of $150.6 million ($0.83 EPS). The company has authorized a $250 million share repurchase program and projects 2023 net revenue between $4.15 billion and $4.375 billion.
Option Care Health (NASDAQ: OPCH) will announce its Q4 and full-year results for 2022 on February 23, 2023, before the market opens. The company is the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,500 team members, including 4,500 clinicians. A conference call to discuss these results is scheduled for 8:30 a.m. E.T. the same day. Participants can pre-register for the call or access it via a live audio webcast. A replay will be available shortly after the call for 90 days. For more information, visit OptionCareHealth.com.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 9:00 AM PT in San Francisco. The CEO, John Rademacher, and CFO, Mike Shapiro, will present the company's insights and strategies. Interested parties can view the webcast and presentation materials on their official investor website. Option Care Health employs over 7,500 team members nationwide to enhance patient care.
Option Care Health Inc (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services, is expanding its partnership with WellSky. This collaboration aims to enhance the CareTend platform across 160+ infusion suites. With new automation, clinical decision support, and mobile capabilities, the partnership intends to improve patient outcomes and reduce costs. The initiative builds on over a decade of collaboration between the two companies, focusing on technology innovation in infusion therapy.
Option Care Health, the largest independent provider of home infusion services, reported Q3 2022 financial results with net revenue increasing 14.5% to $1,020.9 million from $891.9 million a year earlier. Gross profit rose 7.4% to $218.0 million, representing 21.4% of net revenue. Net income grew to $38.8 million, or $0.21 per share, up from $35.5 million a year ago. Adjusted EBITDA was $85.6 million, reflecting a 9.8% increase. The company also announced an acquisition of Rochester Home Infusion for $27.4 million. Guidance for 2022 is revised to $3.90 to $3.95 billion in revenue.
Option Care Health (NASDAQ: OPCH) will announce its Q3 2022 earnings on October 27, 2022, before the market opens. The management team will discuss the results in a conference call at 8:30 a.m. E.T. Pre-registration for the call is available, and a live audio webcast will be offered on their investor website. Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., serving patients in all 50 states with over 7,000 team members, including more than 4,000 clinicians.
Walgreens Boots Alliance (WBA) has sold 11 million shares of Option Care Health (OPCH) in a secondary offering, reducing its ownership from 20.5% to 14.4%. The proceeds will primarily be utilized for debt paydown and to support strategic priorities. CEO Rosalind Brewer emphasized the action aligns with the company's strategy and enhances balance sheet flexibility. Walgreens Boots Alliance continues to serve millions through over 13,000 locations worldwide, aiming to improve healthcare access.
Option Care Health announced an affiliate of Walgreens Boots Alliance will sell 11 million shares of the Company’s common stock at $33.25 per share in a secondary offering. This represents about 6% of the current shares outstanding. The offering is expected to close on August 18, 2022, subject to customary conditions. Goldman Sachs is the underwriter for the offering. Option Care Health will not receive any proceeds from this transaction. A shelf registration statement was filed with the SEC for these shares.